Evaluation of a Mobile App to Promote Social Support for Oncology Patients
NCT ID: NCT04331678
Last Updated: 2023-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
230 participants
INTERVENTIONAL
2020-03-12
2021-10-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
Participants will be complete survey at enrollment and then again in 3 months.
No interventions assigned to this group
Active
Participants in the App group will receive usual care and complete survey at enrollment and then again in 3 months.
In addition, they will be asked to download the study app to their mobile device and use it at least once per week during the 3-month study period.
Comparator App
Participants will download and agree to use the study app at least once per week during the 3-month intervention period.
The app allows participants to invite a network of friends and family to provide emotional and logistical support during their treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Comparator App
Participants will download and agree to use the study app at least once per week during the 3-month intervention period.
The app allows participants to invite a network of friends and family to provide emotional and logistical support during their treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must have a confirmed diagnosis of cancer and be prior to or within one month of initiating chemotherapy or immunotherapy
* Have a valid email address
* Have a smart mobile device (Android or iOS) with a data plan
* Willing to download and use the study app
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Emory University
OTHER
West Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Cancer Center
Southaven, Mississippi, United States
West Cancer Center
Germantown, Tennessee, United States
West Cancer Center
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Graetz I, Hu X, Curry AN, Robles A, Vidal GA, Schwartzberg LS. Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial. Cancer Med. 2023 Mar;12(5):6190-6199. doi: 10.1002/cam4.5351. Epub 2022 Oct 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-002b
Identifier Type: -
Identifier Source: org_study_id